Roberto Verna, Roma, 12 Agosto 1947. Professor of Clinical Pathology, Department of Experimental Medicine - Faculty of Medicine, Sapienza University of Rome, Viale Regina Elena, 324 - 00161 Roma, since 1986. President, World Association of Societies of Pathology and Laboratory Medicine; Past President SIPMeL; President, World Pathology Foundation; Member of the ExCo of CIOMS; Member of the Board of FISMeLab; Member of the Board FISM. Degree in Medicine and Surgery; Degree in Biological Sciences; Specialization in Science of Nutrition; General Pathology; Endocrinology, University of Rome, full votes with honors. Appointed of the Chair of Clinical Pathology at the University of L'Aquila then Rome. Visiting Scientist, LMB, NCI. NIH, Bethesda MD; INSERM, Hopital Necker, Paris – France; NIDDKD, NIH, USA. 2004-2011, Director of the Clinical Research Center of the University of Rome 2012- 2017 Director of the Center for Sports Medicine and Management Member of the Board of several Scientific Societies and Organisations. Member of the Commission for the Monitoring and Control of Doping and the Protection of Health in Sporting Activities, Ministry of Health President of the Commission of the Ministry of Health for Soccer synthetic surface Fields Representative of WASPaLM to WHO Member of the Malaysian Academy of Medicine. Member of the Scientific Committee of the Journals: Malaysian Journal of Pathology Human Pathology. Case reports Author of more than 150 publications on the main international Journals. Author of 12 scientific books.
Laboratory of Sports activity; Aging; Dyslipidemias; Endocrinology and Metabolic Diseases; Clinical Value of Laboratory; Molecular Oncology
Kristin is a Managing Director of EY-Parthenon and Global Head of the Life Sciences practice. Based in the Boston office, she has 20 years of experience in the life sciences sector. Kristin is serving clients in the pharmaceutical, biotech, diagnostics and life science tools industries, with a focus on company and investor commercial strategy and M&A support for diagnostics, life science research and pharmaceutical companies. She is also the creator and leader of EY Precision Medicine™. Prior to joining EY in 2013, Kristin was a partner and owner of Health Advances, where she managed the firm with four other partners and developed and led a global Diagnostics and Life Sciences practice focused on product and service strategy, corporate strategy, health economics and deal diligence. She is also a founder of DxInsights, a nonprofit organization designed to educate the nation’s health care communities on the impact of diagnostics in improving health care outcomes. Kristin earned a BA in Biochemistry from Smith College and an MS in Epidemiology, Health Management, and Maternal and Child Health from the Harvard School of Public Health.
Yaping Tian, Professor of Department of Clinical Biochemistry, Director of translational medicine laboratory, Chinese PLA General Hospital and Military Medical School. He also be invited as Professor of Nankai University, Tsinghua University. Dr Tian received his Master Degree in Medicine from Chinese PLA Postgraduate Medical School in 1989 and PhD from Academy of Military Medical Sciences in 1993. He had been trained as Postdoctoral Fellow for 2 years(1995-1997) in The Queen Elizabeth Hospital, Australia. Dr. Tian has been focusing on the study of the specific serum proteomic profiles and genetic signatures in different diseases, especially on cancer and cardiovascular diseases. He also focused on the studies of antioxidants in herbal medicine and free radical biology. Dr. Tian has received more than 20 grants and published more than 400 scientific papers in peer-reviewed journals. He is on the editorial boards of several journals and the honor chairman of the Clinical Biochemistry and Applied Molecular Biology Association, CSBMB.
Cancer and Cardiovascular diseases
Dr. Jason X. Cheng stayed at University of Chicago to get his Hematopathology fellow under the guidance of Dr. James W. Vardiman, one of the top authorities in Diagnostic Hematopathology. He completed his fellowship training in 2010, and then became an assistant Professor in University of Michigan at Ann Arbor where he was the head of Epigenetics Laboratory. Dr. Cheng came back to become a faculty in the Hematopathology Section at University of Chicago in 2013. He has quite a few scientific publications and a patent issued by the U.S. patent agency. He also had multiple awards including Cancer Research Foundation Young Investigator Award, the society for Hematopathology Pathologist-in-Training Award, the Paul E. Strandjord Young Investigator Award from Academy of Clinical Physicians and Scientists, the Robert E. Priest Fellowship, …etc.
Dr. Bhattacharjee did her B.Sc in Biotechnology from Bangalore University in 2006 and M.Sc in Applied Genetics from Bangalore University in 2008. She then moved to England to pursue her DPhil (Phd) in Biochemistry from Oxford University where she studied the role of Fml1 and its partner proteins Mhf1 and Mhf2 in promoting genome stability. She was awarded her DPhil in 2012. During her time at Oxford, she was also a tutor at Greene’s College, Oxford. In 2013, Dr. Bhattacharjee moved to Cold Spring Harbor Laboratory, New York. At CSHL, her work has focused on understanding the epigenetic regulation of DNA repair. She is also an academic tutor at the Watson School of Biological studies, the school for graduate studies at CSHL.
Dr. Siew-Khin Tang, known to her friends and colleagues as "Happy", joined Dorevitch Pathology in July 2006. After 17 years at the Alfred Hospital as a Consultant Anatomical Pathologist and Cytopathologist, with a brief stint in private pathology, she returned in 2004 to the Victorian Cytology Service where she had previously worked closely with Dr. Michael Drake (1962 - 1968, 1973 - 1979), the doyen for the Victorian Cervical Cancer Screening Service in the 1960s. Her return to histopathology at Dorevitch Pathology has been prompted by her strong interest in endoscopic biopsies of the Gastrointestinal tract, breast and gynaecological pathology. She is well known for her experience in the wide field of cytopathology, including Fine Needle Aspiration cytology. She is currently expanding her interest in dermatopathology.
Professor Viroj Wiwanitkit is a medical professor and Asian Scholar. He is presently a visiting University Professor, Hainan Medical University, China. He has more than 950 international journal publications and 150 international textbook publications. He is editor in chief and editorial board of more than 40 journals. He has ever been invited to be keynote speakers of many international conferences. He is the Thai scientists with the most number of publications. He is a guest lecturer of many universities.
Larry Nichols, M.D., is professor of pathology and interim chair of the department of pathology of the Mercer University School of Medicine. Before that, he was professor of pathology and vice chair for education at the University of Tennessee College of Medicine. Prior to that, he was associate professor of pathology and chief of the multi-hospital autopsy service for the University of Pittsburgh Medical Center. Before that, he was assistant professor of pathology at the University of Southern California and did autopsies of AIDS patients for all of Los Angeles County. He has also done clinical antibiotic research and worked for the British National Health Service. He earned his M.D. from the University of Wisconsin and did residency training in internal medicine and pathology at the Harvard Medical School New England Deaconess Hospital. Over the years, his research interests have shifted from antibiotics to AIDS to cardiac and pulmonary pathology and, most recently, medical education. Since coming to the Mercer University School of Medicine, Dr. Nichols has been publishing case reports based on the thousands of hospital patient autopsies that he has done, often focused on the lessons for patient safety from those cases. He serves as a scientific editor of the Brazilian journal Autopsy and Case Reports published by the medical school of the University of Sao Paolo and as one of the editors of the Archives of Pathology and Laboratory Medicine published by the College of American Pathologists. Dr. Nichols has joined the group of infectious disease physicians at the Navicent Medical Center and he takes a turn every fourth week presenting cases at their infectious diseases case conference. He is working with the chair of the department of surgery at the Navicent Medical Center in a laboratory bench research study of fibrosis from abdominal surgery. Dr. Nichols is collaborating with individuals at the medical school of the Free University of Brussels in Belgium, which hosts his website of virtual slides and associated patient histories, freely accessible for medical education anywhere in the world.
Cardiac and Pulmonary Pathology
Doctor Ana Paula Oliveira holds a degree in Dentistry from the Federal University of Minas Gerais/Brazil (2001), is a PhD in Periodontology. She completed the Research Scholar Program in Periodontology at the Forsyth Institute, Boston, USA, and studied Oral Microbiology and Oral Immunology at HARVARD Dental Medical School in Boston, USA (2009). She is currently a Professor of Periodontology at Faculty of Dentistry of Federal University of Uberlândia, Minas Gerais/Brazil, where she do research in the area of periodontal diseases and systemic disturbs such as preterm birth, pre-eclampsia and low birth weight.
Dr. Altaf Taher is currently the Divisional Chief of Pathology at Eastern Health in St. John’s, Canada. He is also employed by the Faculty of Medicine at Memorial University of Newfoundland. He serves as the Program Director of the Residency Training Program in Anatomical Pathology. Altaf received his medical degree from JNMC College in Belgaum, India and went on to do his specialization in Pathology from Kasturba Medical College in Mangalore, India in 1990. After practicing pathology for more than a decade he immigrated to Canada where he was recertified by the Royal College of Physicians of Canada in 2008. He subsequently was a fellow in the Gastrointestinal Pathology division at Brigham and Women’s Hospital in Boston from 2009 to 2010. He also received certification from the American Board of Pathology in 2010. He joined Memorial University as an Assistant Professor in 2009. He became the Residency Program Director in 2014. He has proven skills as a leader and became the Divisional Chief of Pathology in 2016. His interests are mainly in education and he teaches both at the undergraduate and post graduate levels. His specialization in Gastrointestinal Pathology has made him one of the few pathologists with a special interest in pancreato-biliary pathology in the entire province of Newfoundland.
Adenocarcinoma of the GE Junction | Dysplasia in Barrett's | Her2 in Gastric Cancer
Prof Syed Attar is a Diagnostician for human and animal pathology, especially neoplastic lesions( Director of human oncology unit in a famous private lab in Zagazig, Egypt ). He is a Reviewer for local and international journals and is Owner of a medical research center with Good knowledge for electron microscopic studies, nano-particle studies, molecular pathology, and immunohistochemistry. He is a visiting professor for many regional universities.
Molecular pathology, and Immunohistochemistry
Dr. Alain L Fymat is a medical scientist and an educator. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine and Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center. He has extensively published (~ 350 publications including patents, books & monographs, book chapters, refereed articles) and has lectured extensively in the USA, Africa and Asia. He has been the recipient of numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He is Honorable Editor of the International Journal of Cancer Prevention and Current Research and the International Journal of Nanomedicine Research. He s also Editor of the Global Journal of Nanomedicine and the Journal of Nanobiotechnology. He is a Board member of several institutions and Health Advisor of the American Heart & Stroke Association (Coachella Valley Division, California).
Dr. Fymat’s current research interests lie at the interface between science and medicine, particularly molecular/personal/precision medicine, nanomedicine, human genetics/epigenetics/ecogenetics, and pharmacogenomics. His most recent publications deal with magnetic resonance Imaging with nanocontrasting materials, nanotechnology and cancer, nanochemotherapy, nanoneurology, natural and synthetic immunotherapy, drug delivery including across the brain protective barriers, and drug manufacturing in Africa.